NLS Pharmaceutics Shareholders Approve Merger with Kadimastem and Related Proposals at Extraordinary General Meeting
Provided By PR Newswire
Last update: Sep 30, 2025
Vote clears final corporate milestone, paving the way for the closing of the merger and the combined company of NewCelX Ltd., a Nasdaq-listed biotechnology company
Read more at prnewswire.com1.65
+0.02 (+1.23%)
NASDAQ:NLSPW (10/17/2025, 8:00:01 PM)
0.025
+0 (+24.38%)
Find more stocks in the Stock Screener
NLSP Latest News and Analysis
